Injectable Semaglutide has not been evaluated by the FDA, but side effects are expected to be similar to other Semaglutide-based medications reviewed by the FDA, which have the following side effects: nausea, diarrhea, vomiting, constipation, abdominal (stomach) pain, headache, fatigue, dyspepsia (indigestion), dizziness, abdominal distension, eructation (belching), hypoglycemia (low blood sugar), flatulence (gas buildup), gastroenteritis (an intestinal infection), and gastroesophageal reflux disease (a type of digestive disorder)
Tirzepatide, in turn, goes one step further, acting on both GLP-1 and GIP receptors
PMID: 3814350
It is used as a screening tool for type 2 diabetes and its precursor, prediabetes
These tablets should use for skin whitening or full body whitening also